BlackRock Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $4.25M | Sell |
131,453
-178,828
| -58% | -$5.78M | ﹤0.01% | 1157 |
|
|
2016
Q3 | $10.6M | Buy |
310,281
+263,943
| +570% | +$9.03M | 0.01% | 808 |
|
|
2016
Q2 | $1.56M | Buy |
46,338
+20,722
| +81% | +$699K | ﹤0.01% | 1520 |
|
|
2016
Q1 | $1.36M | Sell |
25,616
-140,382
| -85% | -$7.44M | ﹤0.01% | 1572 |
|
|
2015
Q4 | $12.7M | Sell |
165,998
-6,657
| -4% | -$511K | 0.01% | 703 |
|
|
2015
Q3 | $7.1M | Sell |
172,655
-4,529
| -3% | -$186K | 0.01% | 931 |
|
|
2015
Q2 | $12.5M | Buy |
177,184
+127,169
| +254% | +$8.99M | 0.01% | 676 |
|
|
2015
Q1 | $4.44M | Sell |
50,015
-31,602
| -39% | -$2.81M | ﹤0.01% | 977 |
|
|
2014
Q4 | $7.24M | Sell |
81,617
-1,704
| -2% | -$151K | 0.01% | 858 |
|
|
2014
Q3 | $8.08M | Buy |
83,321
+62,631
| +303% | +$6.07M | 0.01% | 825 |
|
|
2014
Q2 | $1.9M | Buy |
20,690
+64
| +0.3% | +$5.88K | ﹤0.01% | 1163 |
|
|
2014
Q1 | $1.44M | Buy |
20,626
+1,825
| +10% | +$128K | ﹤0.01% | 1293 |
|
|
2013
Q4 | $1.08M | Buy |
18,801
+1,205
| +7% | +$69.3K | ﹤0.01% | 1446 |
|
|
2013
Q3 | $846K | Buy |
17,596
+5,050
| +40% | +$243K | ﹤0.01% | 1512 |
|
|
2013
Q2 | $364K | Buy |
+12,546
| New | +$364K | ﹤0.01% | 2059 |
|